{{Rsnum
|rsid=2854275
|Gene=HLA-DQB1
|Chromosome=6
|position=32660651
|Orientation=minus
|GMAF=0.06244
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 84.1 | 15.9 | 0.0
| HCB | 88.3 | 11.7 | 0.0
| JPT | 93.0 | 7.0 | 0.0
| YRI | 85.7 | 13.6 | 0.7
| ASW | 93.0 | 7.0 | 0.0
| CHB | 88.3 | 11.7 | 0.0
| CHD | 92.7 | 7.3 | 0.0
| GIH | 82.2 | 16.8 | 1.0
| LWK | 89.1 | 10.9 | 0.0
| MEX | 77.6 | 22.4 | 0.0
| MKK | 80.1 | 18.6 | 1.3
| TSI | 79.4 | 20.6 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23326239
  |Trait=Epstein-Barr virus immune response (EBNA-1)
  |Title=A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
  |RiskAllele=T
  |Pval=2E-10
  |OR=.45
  |ORtxt=[NR] unit decrease
  |OA=1
}}

{{ClinVar
|ALT=A
|CAF=0.9376; 0.06244
|CHROM=6
|CLNALLE=-1; 1
|CLNHGVS=NC_000006.11:g.32628428C; NC_000006.11:g.32628428C>A
|CLNSIG=7
|COMMON=1
|FwdALT=T
|FwdREF=G
|GENEINFO=HLA-DQB1:3119
|GENE_ID=3119
|GENE_NAME=HLA-DQB1
|REF=C
|RSPOS=32628428
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;INT;VLD;G5;HD;GNO;KGPhase1;KGPilot123;KGPROD;OTHERKG;PH3;LSD
|VC=SNV
|VP=0x05006008000115051f100100
|WGT=1
|dbSNPBuildID=100
|rsid=2854275
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}